geraniol has been researched along with Alloxan Diabetes in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
El Azab, EF; Mostafa, HS | 1 |
Arvindekar, AU; Ghadyale, VA; Haldavnekar, VS; Kamble, SP; Patil, RS | 1 |
Prasad, SN | 1 |
El-Bassossy, HM; Elberry, AA; Ghareib, SA | 1 |
4 other study(ies) available for geraniol and Alloxan Diabetes
Article | Year |
---|---|
Geraniol ameliorates the progression of high fat-diet/streptozotocin-induced type 2 diabetes mellitus in rats via regulation of caspase-3, Bcl-2, and Bax expression.
Topics: Acyclic Monoterpenes; alpha-Amylases; alpha-Glucosidases; Animals; bcl-2-Associated X Protein; Caspase 3; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Molecular Docking Simulation; Rats; Rats, Wistar; Streptozocin | 2022 |
Inhibition of GLUT2 transporter by geraniol from Cymbopogon martinii: a novel treatment for diabetes mellitus in streptozotocin-induced diabetic rats.
Topics: Acyclic Monoterpenes; Animals; Cymbopogon; Diabetes Mellitus, Experimental; Glucose Transporter Type 2; Glycated Hemoglobin; Hyperglycemia; Male; Rats; Rats, Wistar; Streptozocin | 2020 |
Protective effects of geraniol (a monoterpene) in a diabetic neuropathy rat model: attenuation of behavioral impairments and biochemical perturbations.
Topics: Acyclic Monoterpenes; Administration, Oral; Animals; Body Weight; Brain; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Hydrogen Peroxide; Hyperalgesia; Hypoglycemic Agents; Lipid Peroxidation; Male; Malondialdehyde; Oxidoreductases; Psychomotor Disorders; Rats; Rats, Wistar; Reactive Oxygen Species; Sciatic Nerve; Terpenes | 2014 |
Geraniol improves the impaired vascular reactivity in diabetes and metabolic syndrome through calcium channel blocking effect.
Topics: Acyclic Monoterpenes; Animals; Aorta; Calcium Channel Blockers; Calcium Channels; Diabetes Mellitus, Experimental; Endothelium, Vascular; In Vitro Techniques; Male; Metabolic Syndrome; Rats; Rats, Wistar; Terpenes; Vasodilation; Vasodilator Agents | 2016 |